How Oral Targeted Therapies and IV Immunotherapies Disrupted Community Practice Financing

Barbara McAneny, MD, the chief executive officer of New Mexico Cancer Center, discusses how oral targeted therapies and immunotherapies disrupted the traditional methods for financing community practices.